FHA
CODX

First Horizon Advisors’s Co-Diagnostics CODX Stock Holding History

First Horizon Advisors’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-47
Closed -$1.55K – 2414
2023
Q2 		$1.55K Buy
+47
New +$1.8K ﹤0.01% 2154

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Horizon Advisors's CODX Position: Q3 2023 in Review

First Horizon Advisors sold out of Co-Diagnostics (CODX) in Q3 2023, closing a stake of 47 shares — an estimated $1.55K sold.

First Horizon Advisors first reported a position in CODX in Q2 2023 and held it in 1 quarter. The position peaked at $1.55K in Q2 2023. 43 funds tracked by Wall St. Rank hold CODX as of Q3 2023.

  • First Horizon Advisors reported no remaining Co-Diagnostics position as of Q3 2023 after selling out during the quarter.
  • First Horizon Advisors sold 47 Co-Diagnostics shares in Q3 2023, an estimated $1.55K.
  • First Horizon Advisors first reported a position in Co-Diagnostics in Q2 2023 and held it in 1 quarter.
  • First Horizon Advisors's Co-Diagnostics position peaked at $1.55K in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2023.

Based on First Horizon Advisors's 13F filing for Q3 2023, filed 27 Oct 2023.